Phio Pharmaceuticals - Warrants (21/12/2021) Net Tangible Assets

The latest net tangible assets for PHIOW is $13M as of June 2026. That compares with $10M in the prior-year period — up 24.8% year over year. Investors often review this figure alongside Phio Pharmaceuticals - Warrants (21/12/2021)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PHIOW's net tangible assets moved from $10M to $13M — a 24.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Phio Pharmaceuticals - Warrants (21/12/2021)'s operating scale or balance-sheet position.

A net tangible assets figure of $13M for PHIOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PHIOW's net tangible assets ($13M), review year-over-year change from $10M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Phio Pharmaceuticals - Warrants (21/12/2021)'s net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.